Package 67184-0511-1

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67184-0511-1
Digits Only 6718405111
Product NDC 67184-0511
Product ID 67184-0511_5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056
Description

1 VIAL, SINGLE-USE in 1 CARTON (67184-0511-1) / 2 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2016-05-03
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056", "openfda": {"upc": ["0367184051311"], "unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324", "1726333"], "spl_set_id": ["afcdde49-ec0c-4c56-a1af-2917185b1a08"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (67184-0511-1)  / 2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "67184-0511-1", "marketing_start_date": "20160503"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "67184-0511_5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "67184-0511", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA203380", "marketing_category": "ANDA", "marketing_start_date": "20160503", "listing_expiration_date": "20261231"}